Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 5/20 | 0.64 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.54 |
| ▸ | DRD2 | P14416 | 1/20 | 0.44 |
| ▸ | DRD4 | P21917 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CCR1 | P32246 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15862739 | 0.96 | OPRM1 (0.64) | OPRM1MAP4K4DRD2DRD4DRD3 | |
| SCHEMBL1074339 | 0.94 | OPRM1 (0.62) | OPRM1MAP4K4DRD2DRD4DRD3 | |
| SCHEMBL31441141 | 0.94 | OPRM1 (0.62) | OPRM1MAP4K4DRD2DRD4DRD3 | |
| SCHEMBL648009 | 0.91 | OPRM1 (0.68) | OPRM1MAP4K4DRD2DRD4DRD3 | |
| SCHEMBL14061628 | 0.84 | OPRM1 (0.53) | OPRM1MAP4K4DRD2DRD4DRD3 | |
| SCHEMBL2301089 | 0.84 | OPRM1 (0.60) | OPRM1MAP4K4DRD2DRD4DRD3 | |
| SCHEMBL625403 | 0.82 | OPRM1 (0.58) | OPRM1MAP4K4DRD2DRD4DRD3 | |
| SCHEMBL651535 | 0.82 | OPRM1 (0.58) | OPRM1MAP4K4DRD2DRD4DRD3 | |
| Hydrochloric Acid SCHEMBL1001869 | 0.81 | OPRM1 (0.61) | OPRM1MAP4K4DRD2DRD4DRD3 | |
| SCHEMBL11073259 | 0.81 | OPRM1 (0.57) | OPRM1MAP4K4DRD2DRD4DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 239 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119060088-A | Methyl parathion hapten, sibutramine hapten, methyl parathion-sibutramine artificial antigen, antibody and detection kit | 天地壹号饮料股份有限公司 | 2024-12-03 | — | — | CN | claimed |
| EP-4305026-B1 | ANTI-INFLAMMATORY CARBOXAMIDE DERIVATIVES | BIOMEDCODE HELLAS SA (GR) | 2025-05-07 | — | — | EP | disclosed |
| CN-119060088-A | Methyl parathion hapten, sibutramine hapten, methyl parathion-sibutramine artificial antigen, antibody and detection kit | 天地壹号饮料股份有限公司 | 2024-12-03 | — | — | CN | disclosed |
| US-20240317686-A1 | RORyT MODULATOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | SHANGHAI PHARMACEUTICALS HOLDING CO., LTD. (CN) | 2024-09-26 | — | — | US | disclosed |
| US-20240174603-A1 | MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME | RAPPTA THERAPEUTICS OY (FI) | 2024-05-30 | — | — | US | disclosed |
| EP-4288412-A1 | MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME | Rappta Therapeutics Oy (FI) | 2023-12-13 | — | — | EP | disclosed |
| EP-4273129-A1 | RORgammaT MODULATOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Shanghai Pharmaceuticals Holding Co., Ltd. (CN) | 2023-11-08 | — | — | EP | disclosed |
| EP-4273129-A1 | RORgammaT MODULATOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Shanghai Pharmaceuticals Holding Co., Ltd. (CN) | 2023-11-08 | — | — | EP | disclosed |
| CN-114773136-B | Method for synthesizing aromatic amine | 陕西师范大学 | 2023-06-16 | — | — | CN | disclosed |
| EP-3362445-B1 | OXADIAZOLE AMINE DERIVATIVE COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR, AND THE PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | CHONG KUN DANG PHARMACEUTICAL CORP (KR) | 2023-01-25 | — | — | EP | disclosed |
| US-4522828-A | CYCLOBUTYLALKYLAMINE COMPOUNDS, ANTIDEPRESSANTS | THE BOOTS COMPANY PLC (GB) | 1985-06-11 | — | — | US | disclosed |
| EP-0111994-A1 | (1-Arylcyclobutyl) alkylamine derivatives, their preparation and their use as therapeutic agents | The Boots Company PLC (GB) | 1984-06-27 | — | — | EP | disclosed |
| EP-0108488-A1 | (1-Arylcyclobutyl) (heterocyclyl) methylamine compounds, their preparation and their use as therapeutic agents | The Boots Company PLC (GB) | 1984-05-16 | — | — | EP | disclosed |
| US-4443449-A | Arylcyclobutylalkylamines and anti-depression composition and methods using same | THE BOOTS COMPANY LIMITED (GB) | 1984-04-17 | — | — | US | disclosed |
| US-4355042-A | A CYCLOBUTANE CARBOXYLIC ACID DERIVATIVE | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) | 1982-10-19 | — | — | US | disclosed |
| US-4348409-A | MITICIDES, NEMATOCIDES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) | 1982-09-07 | — | — | US | disclosed |
| US-4339458-A | HALOCYCLOBUTANECARBOXYLATES | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) | 1982-07-13 | — | — | US | disclosed |
| EP-0002620-B1 | CYCLOALKYL CARBOXYLIC ESTERS, INSECTICIDAL COMPOSITIONS CONTAINING THEM, AND METHODS FOR THEIR PREPARATION | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1981-11-25 | — | — | EP | disclosed |
| US-4235926-A | DERIVATIVES OF CYCLOBUTANE | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) | 1980-11-25 | — | — | US | disclosed |
| EP-0002620-A1 | Cycloalkyl carboxylic esters, insecticidal compositions containing them, and methods for their preparation | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1979-06-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240317686-A1 | RORyT MODULATOR, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | RORC, RORB, RORA | OPRM1 3437/4885MAP4K4 3496/4885DRD2 4433/4885 |
| US-20240174603-A1 | MODULATORS OF PROTEIN PHOSPHATASE 2A (PP2A) AND METHODS USING SAME | PPM1A, PPP2CA, PPP3CA | OPRM1 4413/4885MAP4K4 794/4885DRD2 4726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.